Search results
Showing results for
Pioneering gene therapy has restored some vision to John Radcliffe Hospital patients with a rare form of genetic blindness for as long as four years, raising hopes it could be used to cure common causes of vision loss, new University of Oxford research published today shows.
Sridhar Vasudevan
Sridhar Vasudevan - Associate Professor in Pharmacology and Drug Discovery
Paul Harrison
MA, BM. BCh, DM (Oxon), FRCPsych Paul Harrison - Professor of Psychiatry; Associate Head of Department (Research)
Jasmina Cehajic-Kapetanovic
M.A. Phy. Sci., B.M. B.Ch. Oxon., M.Sc. I.O.V.S., M.R.C.Ophth., Ph.D., F.R.C.Ophth. Jasmina Cehajic-Kapetanovic - MRC Clinician Scientist and Consultant Vitreo-Retinal Surgeon
Masud Husain
MA DPhil BMBCh FRCP FMedSci FAAN FEAN Masud Husain - Professor of Neurology & Cognitive Neuroscience
Steven Middleton
Steven Middleton - Senior Postdoctoral Researcher
Ruxandra Dafinca
MSc DPhil Ruxandra Dafinca - Alzheimer's Society Dementia Research Leader Fellow
Andreas Themistocleous
BSc(Hons), MBBCh, PhD, FCP (SA), MRCP (UK) Andreas Themistocleous - Associate Professor and MRC Clinician Scientist Fellow
Gwenaëlle Douaud
Gwenaëlle Douaud - Associate Professor
William Clarke
William Clarke - Associate Professor & Wellcome Career Development Fellow
Kanmin Xue
MA MBBChir PhD FRCOphth Kanmin Xue - Associate Professor
Melanie Fleming
Melanie Fleming - Associate Professor & Academic Lead for Patient Involvement and Public Engagement
Heidi Johansen-Berg
Heidi Johansen-Berg - Pro-Vice Chancellor (Strategic Initiatives)